Overview

Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of DWJ1319 in the prevention of gallstone formation after gastrectomy in patient with gastric cancer. Two-thirds of the participants will receive DWJ1319, while the other will receive a placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.